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Neuregulin 1 (NRG1) regulates the expression of the nicotinic acetylcholine receptor
(nAChR) and is suggested to promote the survival and maintenance of the enteric
nervous system (ENS), since deficiency of its corresponding receptor complex
ErbB2/ErbB3 leads to postnatal colonic aganglionosis. As diverticular disease (DD) is
associated with intestinal hypoganglionosis, the NRG1-ErbB2/ErbB3 system and the
nAChR were studied in patients with DD and controls. Samples of tunica muscularis of
the sigmoid colon from patients with DD (n = 8) and controls (n = 11) were assessed
for mRNA expression of NRG1, ErbB2, and ErbB3 and the nAChR subunits α3, α5,
α7, β2, and β4. Site-specific gene expression levels of the NRG1-ErbB2/3 system were
determined in myenteric ganglia harvested by laser microdissection (LMD). Localization
studies were performed by immunohistochemistry for the NRG1-ErbB2/3 system and
nAChR subunit β4. Rat enteric nerve cell cultures were stimulated with NRG1 or
glial-cell line derived neurotrophic factor (GDNF) for 6 days and mRNA expression
of the aforementioned nAchR was measured. NRG1, ErbB3, and nAChR subunit β4
expression was significantly down-regulated in both the tunica muscularis and myenteric
ganglia of patients with DD compared to controls, whereas mRNA expression of
ErbB3 and nAChR subunits β2, α3, α5, and α7 remained unaltered. NRG1, ErbB3,
and nAChR subunit β4 immunoreactive signals were reduced in neuronal somata and
the neuropil of myenteric ganglia from patients with DD compared to control. nAChR
subunit β4 exhibited also weaker immunoreactive signals in the tunica muscularis of
patients with DD. NRG1 treatment but not GDNF treatment of enteric nerve cell cultures
significantly enhanced mRNA expression of nAchR β4. The down-regulation of NRG1
and ErbB3 in myenteric ganglia of patients with DD supports the hypothesis that
intestinal hypoganglionosis observed in DD may be attributed to a lack of neurotrophic
factors. Regulation of nAChR subunit β4 by NRG1 and decreased nAChR β4 in patients
with DD provide evidence that a lack of NRG1 may affect the composition of enteric
neurotransmitter receptor subunits thus contributing to the intestinal motility disorders
previously reported in DD.
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INTRODUCTION
Diverticular disease (DD) is one of the most common diseases in
western countries with high prevalence especially in the elderly.
It is characterized by multiple mucosal/submucosal herniations
(pseudo-diverticula) through the colonic muscle coat which can
lead to a broad spectrum of symptoms with potentially lethal
complications (Jun and Stollman, 2002). Despite the considerable
burden of DD on the healthcare system (Sandler et al., 2002),
the pathogenesis of DD is still discussed controversially and
appears to be multifactorial. Increasing age, low-fiber diet,
and connective tissue alterations are considered traditionally
as risk factors for the formation of colonic diverticula (Strate
et al., 2009; Böttner and Wedel, 2012). Moreover, previous
reports have given evidence for an underlying enteric neuropathy
in DD characterized by a decrease of myenteric nerve cells
(oligoneuronal hypoganglionosis) and reduced nerve fibers
within smooth muscle layers (Golder et al., 2003; Iwase et al.,
2005; Deduchovas et al., 2008; Wedel et al., 2010). It is postulated
that the disturbed innervation gives rise to colonic motility
disorders frequently reported in DD (Bassotti et al., 2001) thereby
promoting the development of diverticula.
Although a loss of enteric neurons represents a
common histopathologic phenotype within the spectrum of
gastrointestinal neuromuscular pathology (Knowles et al., 2010),
the pathomechanisms leading to the reduced ganglionic nerve
cell content observed in DD remain unclear. Moreover, the
underlying cellular and molecular mechanisms leading to DD
are largely unknown (Simpson and Spiller, 2002). However, since
DD is associated with a lack of glial-cell line derived neurotrophic
factor (GDNF) and its corresponding receptors (Böttner et al.,
2013), a general involvement of neurotrophic factors may play
a role in the pathogenesis of DD, e.g., a deficient GDNF system
could be a primary trigger for the reduced neuronal number
shown in DD (Barrenschee et al., 2017).
Neuregulin 1 (NRG1) belongs to a family of growth factors
that contain an epidermal growth factor domain and activates
the ErbB2/ErbB3 tyrosine kinases in neural crest cells (Britsch
et al., 1998; Garratt et al., 2000). NRG1 is crucial for various
functions in the nervous system, e.g., nerve cell differentiation,
neurite outgrowth, and synapse formation (Falls, 2003; Mei
and Nave, 2014). Isoforms of the neuregulin 1 gene can be
classified into three groups (type I–III) (Falls, 2003), where type
I isoforms [neu differentiation factor (NDF); heregulin (HRG);
acetylcholine receptor inducing activity (ARIA)] have been
implicated in neuromuscular junction formation by stimulating
muscular nicotinic acetylcholine receptor (nAChR) expression
during development (Martinou et al., 1991; Falls et al., 1993).
The importance of NRG1 and its receptor signaling system
ErbB2/ErbB3 in the enteric nervous system (ENS) became
evident, when NRG1 or its corresponding receptors were
ablated in animals. Immunoglobulin-like-NRG1 deficient mice
were found to show approximately 50% reduction in the
number of AChRs at neuromuscular synapses and reduced
synaptic strength (Sandrock et al., 1997). Additionally, ErbB3−/−
mice exhibited a total loss of enteric glia and reduced
ganglionic number in the duodenum (Erickson et al., 1997;
Riethmacher et al., 1997), and enteric neurons and glial cells
were dramatically reduced in conditional ErbB2/Nestin-Cre
mutant mice displaying an Hirschsprung’s disease-like phenotype
(Crone et al., 2003). Recently, we could demonstrate that NRG1
acts as a neurotrophic factor for the ENS, since it promotes
the growth and differentiation of postnatal enteric neurons
(Barrenschee et al., 2015).
Excitatory nicotinic cholinergic transmission is essential for
the regulation of gastrointestinal motility and mediated by
neuronal nAChRs in the ENS (Galligan and North, 2004).
nAChRs are ligand-gated pentameric ion channels found both
in the central and peripheral nervous systems composed of
various combinations of alpha and non-alpha subunits (Sargent,
1993; Dani and Bertrand, 2007) resulting in specific nAChR
subtypes. In the mammalian nervous system, eight ligand binding
α (α2–α7, α9–α10) and three structural β (β2–β4) subunits have
been identified. Neuronal nAChRs are widely expressed in the
central and peripheral nervous systems in adults and during
development (Albuquerque et al., 2009). Whereas in the central
nervous system the majority of nAChRs are either heteromeric
α4β2 containing nAChRs or homomeric α7 nAChRs, in the
peripheral nervous system heteromeric α3β4-type nAChRs with
or without α5 are the predominant receptors (Mao et al., 2006).
Although the expression of nAChRs in the ENS is less well
established, it is known that enteric neurons contain α3, α5, α7,
β2, and β4 subunit proteins which form different heteromeric
nAChR subtypes (Obaid et al., 2005; Grundy and Schemann,
2006; Mandl and Kiss, 2007). In the peripheral nervous system,
α3β4-type nAChRs are considered to represent the predominant
receptors (Galligan and North, 2004).
Since DD is associated with a partial loss of enteric neurons
and a lack of the nerve growth factor GDNF with concomitant
intestinal motility disturbances, we raised the question whether
the NRG1 growth factor system and the enteric nAchR subunit
composition are also altered in DD, thereby contributing to the
intestinal hypoganglionosis and motility dysfunctions in DD.
MATERIALS AND METHODS
Patients
Control Group
Segments of sigmoid colon were obtained from patients
(n = 10, four females, six males, mean age: 69.0 years) who
underwent anterior rectal resection or left hemicolectomy for
non-obstructive colorectal carcinoma. Anorectal evacuation and
colonic motility disorders were previously excluded. None of
the patients showed colonic diverticula. Full-thickness specimens
were harvested from the sigmoid colon at safe distance
(>5 cm) from the tumor.
Patients With DD
Segments of sigmoid colon were obtained from patients (n = 8,
two females, six males, mean age: 62.0 years) who underwent
sigmoid resection or left hemicolectomy for symptomatic DD
(e.g., left-sided abdominal pain, meteorism, altered bowel habits).
Patients were operated by elective surgery during symptom-free
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interval after two or more episodes of diverticulitis. Time between
last episode and surgery ranged from 4 weeks to several months.
Two patients showed non-obstructing stenotic narrowing of
the sigmoid colon and one patient a covered perforation with
paracolic abscess. Patients with emergency surgery for peritonitis
due to open perforation or with complications due to obstructed
stenosis and fistula formation have been excluded from the study.
Full-thickness specimens were harvested from sites at a distance
>1 cm from diverticula. Diverticula-containing areas displaying
an altered anatomy of the colonic wall due to transmural
mucosal herniation or fibrotic/inflammatory processes were
excluded from tissue sampling. The study of human tissue
received approval from the Local Ethics Committee of the
Faculty of Medicine, Christian-Albrechts University of Kiel,
Germany (B299/07).
Tissue Preparation
Tissue Processing for mRNA Expression Profiles of
the Tunica Muscularis and LMD Samples
The tunica muscularis was isolated from full-thickness biopsies
of the colonic wall, immediately frozen in isopentane and stored
at −70◦C until use. Prior to RNA isolation 20 orthogonal
cryosections (10 µm) were cut on a cryostat and collected in
RNA lysis buffer (Macherey and Nagel, Düren, Germany). For
isolation of myenteric ganglia orthogonal cryosections (10 µm)
from full-thickness biopsies were placed on membrane-coated
(polyethylene naphtalate, 1.0 µm, Zeiss, Göttingen, Germany)
slides. To visualize myenteric ganglia sections were ultra-rapidly
(ca. 60 s) stained with toluidine blue and air-dried.
Tissue Processing for Immunohistochemical Studies
After surgical removal, all specimens were transferred into
phosphate-buffered saline (PBS) (pH 7.2) at 37◦C to allow
adaption and further dissection. Full-thickness rectangular tissue
blocks (30 mm× 10 mm) were pinned out flat on a cork plate by
fine needles without artificial stretching nor shortening, thereby
preserving the original size. The longer border of the tissue block
was orientated perpendicular to the gut axis and corresponded
to the cutting surface for histologic sections, so that myocytes
of the circular muscle layer were cut along their longitudinal
axis. After fixation (4% paraformaldehyde in PBS) for 24 h and
dehydration tissue blocks were transferred into paraffin wax and
cut in sections (6 µm) for immunohistochemistry.
Laser Microdissection and Pressure
Catapulting
Laser microdissection (LMD) was performed by a modified
method described previously (Böttner et al., 2010). Briefly,
myenteric ganglia and smooth muscle cells of the tunica
muscularis were identified by inverse light microscopy (Zeiss
Axio Observer Z1, Zeiss, Göttingen, Germany), excised by LMD,
and collected by laser pressure catapulting (PALM MicroLaser
System, Zeiss, Göttingen, Germany) in caps of 0.5 mL reaction
tubes. Ganglionic and smooth muscle tissue areas of 2 mm2 per
specimen were collected, immediately dissolved in 350 µL RNA
lysis buffer (Macherey and Nagel, Düren, Germany), and stored
at−70◦C until further use.
RNA Extraction and Reverse
Transcription
Extraction of total RNA from human tissue was performed using
a Nucleospin II kit (Macherey and Nagel, Düren, Germany);
RNA from enteric nerve cell cultures was isolated using a
Nucleospin XS kit (Macherey and Nagel, Düren, Germany)
according to the manufacturer’s guidelines. Prior to reverse
transcription, contaminating genomic DNA was digested in a
volume of 15 µL using 1.5 U of DNAse I (Sigma, Munich,
Germany). Reverse transcription was carried out in a total
volume of 30 µL containing 200 ng RNA, 375 ng random
hexamer primer (GE Healthcare, Freiburg, Germany), 0.5 mM
dNTPs (Promega, Mannheim, Germany), 0.01 M DTT, 1×
reaction buffer, and 150 U Superscript II Reverse Transcriptase
(Invitrogen, Karlsruhe, Germany). The annealing, elongation,
and denaturation steps were carried out at 25◦C for 10 min, at
42◦C for 50 min, and at 70◦C for 15 min, respectively.
Quantitative PCR
Quantitative PCR (qPCR) reactions were run on an ABI Prism
7700 Sequence Detection System (TaqMan, Applied Biosystems,
Foster City, CA, United States). Amplification reactions were
carried out in a 20 µL volume containing 1× qPCR Master
Mix Plus (Eurogentec, Cologne, Germany), 900 nM primers,
225 nM hybridization probe, and 2 µL cDNA. Samples were run
in duplicate and amplified over 45 cycles. Each cycle consisted of a
denaturation phase of 15 s at 95◦C and a hybridization/elongation
phase of 1 min at 60◦C. mRNA expression profiles were measured
for NRG1, ErbB2, ErbB3, nAchRb2, nAchRb4, nAchRa3,
nAchRa5, nAchRa7, and the housekeeping gene HPRT in human
samples, and for nAchRb2, nAchRb4, nAchRa3, nAchRa5,
nAchRa7, and hprt in rat enteric cell cultures. Forward and
reverse primers and probes are listed below.
Primers Amplifying Human Sequences
NRG1 type I HRGβ1 (NM_013956.3): forward primer: 5′-
atggaggcggaggagctgta-3′, reverse primer: 5′-ttgcagtaggccaccacaca-
3′, probe: 5′-tgaccataaccggcatctgcatcgc-3′; ErbB2 (NM_004448.2):
forward primer: 5′-ggaagtacacgatgcggagact-3′, reverse primer: 5′-
tctctttcaggatccgcatctg-3′, probe: 5′-tggagccgctgacacctagcgga-3′;
ErbB3 (NM_001982.3): forward primer: 5′-tgccatcttcgtcatgttgaac-
3′, reverse primer: 5′-tcaatataaacaccccctgacagaa-3′, probe:
5′-agctccgcttgactcagctcaccga; nAchRb2 (NM_000748), forward
primer: 5′-tgaggcgataatcttcccactc-3′, reverse primer: 5′-gcttatgg
tgtcactggccc-3′, probe: 5′-tcagtgtgcatgagcgggagcaga-3′, nAchRb4
(NM_000750) forward primer: 5′-caaccagatgcgctttgca-3′,
reverse primer: 5′-tctggctgaaacaggaatgga-3′, probe: 5′-cctggaaca
gctcccgctacgaggg-3′, nAchRa3 (NM_000743): forward primer
5′-ccgacatcacatactcgctgtaca-3′: reverse primer: 5′-gacgagcacag
tgaggaagga-3′, probe: 5′-ccggcgcctgcccttgttctaca-3′, nAchRa5
(NM_000745): forward primer: 5′-aaccgtcttcgctatcaacattca-3′,
reverse primer: 5′-gcagtttgggaagcgtgtga-3′, probe: 5′-catggcgccttt
ggtccgcaag-3′, nAchRa7 (NM_000746): forward primer: 5′-agaa
tgggacctagtgggaatcc-3′, reverse primer: 5′-ggcgcatggtcactgtgaa-3′,
probe: 5′-tgctgcaaagagccctaccccgatg-3′, HPRT (NM_000194.2,
house-keeping gene): forward primer: 5′-tgaacgtcttgctcga
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gatgtg-3′, reverse primer: 5′-ccagcaggtcagcaaagaattt-3′, probe:
5′-tgggaggccatcacattgtagcc-3′.
Primers Amplifying Rat Sequences
NRG1 type I HRGβ1 (AY973244.1) forward primer: 5′-ctac
cagaagagggtgctgacaa-3′, reverse primer: 5′-gccgctgcttcttggtttt-3′,
probe: 5′-ctgctggtggtcggcatcttgtgtg-3′; ErbB2 (NM_017003.2):
forward primer: 5′-gctgctgcaggaaactgagttag-3′, reverse primer:
5′-ccttccttagctccgtctcttttag-3′, probe: 5′-ctgacgcccagcggagcaatgc-3′;
ErbB3 (XM_006240755.1) forward primer: 5′-cgaggagatgcgag
ctttcc-3′, reverse primer: 5′-aaagcctgctgtgccagtaatc-3′, probe:
5′-ccccatgttcgttatgcccgcct; nAchRb2 (NM_019297.1), forward
primer: 5′-cattcgtcgcaaaccactcttc-3′, reverse primer: 5′-ccacagt
ctgagggcaggtaga-3′, probe5′-ctgcgtactcatcacctcgctggcc-3′, nAchRb4
(NM_052806.2) forward primer: 5′-atggtgcccagaatacacacaaa-3′,
reverse primer: 5′-gaccgagatcaaagtgtcatcga-3′, probe: 5′-agttc
gtcgcgatggttgttgaccg-3′, nAchRa3 (NM_052805.2): forward
primer 5′-attggaagtacgttgccatggt-3′: reverse primer: 5′-gccatcaag
ggttgcagaaa-3′, probe: 5′-tggtgtgcattttaggaacggcggg-3′, nAchRa5
(NM_017078.2): forward primer: 5′-gcacgaaaacagttgtcaggtaca-3′,
reverse primer: 5′-gatcaaacgggaaaaaggtaacg-3′, probe: 5′-ctgtc
acgtggacgcaaccagcaaa-3′, nAchRa7 (NM_012832.3): forward
primer: 5′-atgccacgttccacaccaat-3′, reverse primer: 5′-ccagcgaa
cgtcaatgtagca-3′, probe: 5′-tctccctccaggcatattcaagagc-3′, hprt
(NM_012583.2, house-keeping gene): forward primer: 5′-cgccag
cttcctcctcaga-3′, reverse primer: 5′-ggtcataacctggttcatcact-3′,
probe: 5′-ttttcccgcgagccgaccgg-3′.
Enteric Nerve Cell Cultures
Preparation of myenteric nerve cells was performed according
to a method described previously (Schäfer et al., 1997). Briefly,
after removing the small intestine from newborn Wistar rats
(postnatal day 2–3), the tunica muscularis was stripped from
the mucosa, followed by incubation for 2 h at 37◦C in
Ca2+- and Mg2+-free Hanks’ Balanced Salt Solution (HBSS,
Gibco Life Technologies/Invitrogen, Karlsruhe, Germany) with
antibiotics containing 1 mg/mL collagenase (Sigma, Munich,
Germany). Afterward, fragments of myenteric plexus were
collected under stereomicroscopic control and incubated for
15 min at 37◦C in trypsin/EDTA (0.125 mg/mL Gibco, Life
Technologies, Germany) to dissociate the plexus. The procedure
was stopped by replacing trypsin/EDTA with fetal calf serum
(FCS, Gibco, Life Technologies/Invitrogen, Karlsruhe, Germany).
The cells were triturated, counted, and seeded at a density
of 100,000 cells/mL on poly-D-Lysin-(Sigma)/Laminin-(Sigma,
Munich, Germany) coated coverslips for immunocytochemistry
studies or 12-well-plates for gene expression studies. Cells
were incubated in defined medium consisting of Neurobasal
A (Gibco, Life Technologies/Invitrogen, Karlsruhe, Germany)
and B27 supplement (Gibco, Life Technologies/Invitrogen,
Karlsruhe, Germany). Additionally, recombinant human NRG1-
β1 (Thr176-Lys246, EGF Domain) (R&D Systems, Minnesota,
MN, United States) or recombinant rat GDNF (Peprotech,
Hamburg, Germany) was added to a final concentration of 0
(control), 2, or 10 ng/mL for NRG1-β1 or 50 ng/mL for GDNF.
Cells were cultured for 1 week and medium was changed every
second day.
Immunohistochemistry
Immunoreactive signals were visualized using the avidin–
biotin complex system (Vectastain Elite ABC Kit, Vector
Laboratories, Burlingame, CA, United States). Briefly, paraffin-
embedded tissue sections were incubated with 3% hydrogen
peroxide to block endogenous peroxidase activity, rinsed
in TBS-buffer (TRIS-buffered saline; 10 mM TRIS, 50 mM
NaCl, pH 7.4), and pretreated with citrate buffer (pH 6.0,
95◦C water bath, 20 min for ErbB2 and ErbB3, microwave,
2 × 750nm, 5 min for nAchRβ4). Thereafter, samples were
incubated overnight with a polyclonal rabbit-anti-NRG1 β1
antibody (HRG β1, 1:5001, Aachen, Germany; immunogen
sequence: KKPGKSELRINKAS), polyclonal rabbit-anti-ErbB2
antibody (1:10001, Aachen, Germany), polyclonal rabbit-anti-
ErbB3 antibody (1:20001, Aachen, Germany), or polyclonal
goat-anti-nAChRβ4 antibody (1:500 abcam, Cambridge,
Germany; immunogen sequence: DYRLTWNSSRYEGVN),
diluted in antibody diluent (Invitrogen, Karlsruhe, Germany),
and incubated for 45 min with biotinylated goat anti-rabbit
IgG (1:400, DAKO, Hamburg, Germany). After washing three
times with TBS, sections were incubated for 45 min with an
avidin–biotin complex (Vectastain ABC Standard, Vector
Laboratories, Burlingame, CA, United States) conjugated
with horseradish peroxidase. 3, 3′-diaminobenzidine (DAKO,
Hamburg, Germany) was used as substrate chromogen. Sections
were counterstained with Meyer’s hematoxylin. Omission of
the primary or secondary antibody served as negative controls.
Analysis was carried out with a light optical microscope (Nikon
6000, Nikon, Tokyo, Japan) coupled to a digital camera (Digital
Sight, Nikon, Tokyo, Japan). Data acquisition was performed
with NIS-Elements BR 3.2 software (Nikon, Tokyo, Japan).
Quantitation of Immunofluorescence
Signals
Image acquisition, processing, and analysis were performed
as previously described (Barrenschee et al., 2017). Briefly,
fluorescence immunohistochemical signals of myenteric ganglia
(n = 8) were recorded in specimens of controls and patients with
DD. Recordings were repeated for each myenteric ganglion in
a corresponding blank specimen after omission of the primary
antibody maintaining the same settings (e.g., magnification,
exposure time for antibodies, DAPI staining). All recordings
were performed using a light microscope (Axiovert 200 M,
Zeiss, Germany) coupled to a digital camera [AxioCam MR3
(monochrome), Zeiss, Germany]. Axiovision (version 4.7, Zeiss,
Germany) was used for displaying, managing, and storing
the pictures. Image processing was carried out in ImageJ.
Pictures were transformed to 8 bits, scaled and corrected for
uneven illumination using the background correction plugin
from Terry Wu available at the ImageJ website2 with iteration
of 3 and radius of 6 ptx. Each myenteric ganglion was
marked and the mean gray value (integrated density/µm2
ganglionic tissue) was determined. Eight ganglia per specimen
were analyzed to calculate the mean gray value for each
1antibodies-online.com
2http://rsbweb.nih.gov/ij/plugins/
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specimen. Background correction was calculated using the
formula: Corrected mean gray value = mean gray value (target
specimen) − mean gray value (blank specimen). Data were
normalized to the experimental control and presented as fold
increase of mean gray value.
Statistical Analysis
Comparison of mRNA expression levels of the NRG1 system
and nAchR subunits between the control group and patients
with DD were carried out by using unpaired student’s t-test
with Welch’s correction for unequal variances. Fluorescence
quantification data were analyzed by unpaired student’s t-test;
the effects of NRG1 and GDNF treatment on rat enteric nerve
cell cultures regarding gene expression studies were analyzed by
one-way-ANOVA followed by Bonferroni’s multiple comparison
test (PrismTM, GraphPad, San Diego, CA, United States).
Significant outlier was calculated with Grubb’s test (PrismTM,
GraphPad, San Diego, CA, United States) and removed from
the analysis. Differences were considered significant if p < 0.05
and displayed as ∗, whereas ∗∗ indicates p < 0.01 vs. control
and ∗∗∗ = p < 0.001 vs. control. Results are expressed
as mean± SEM.
RESULTS
Gene Expression Profiles of the NRG1
System and nAchR Subunits in Patients
With DD and Controls
To determine the gene regulation of the NRG1 system in patients
with DD compared to controls, mRNA expression levels of
NRG1 and its corresponding receptors ErbB2 und ErbB3 were
monitored by qPCR. Analysis of the tunica muscularis revealed
that NRG1 mRNA expression was significantly down-regulated
in patients with DD, as mRNA levels dropped to 37 ± 8%
of control values (Figure 1A). The NRG1 receptor ErbB3 also
exhibited significant down-regulation with mRNA expression
levels dropped to 45± 10% of control values (Figure 1C). mRNA
expression of ErbB2 also decreased in patients with DD, however,
not at significant level (Figure 1B).
To analyze the regulation of nAchR subunits in patients
with DD compared to controls, mRNA expression levels of
nAchR subunits α3, α5, α7, β2, and β4 were investigated by
qPCR in the tunica muscularis. Expression levels of α3, α5, and
β4 fall in the same range (1Ct values), whereas subunits β2
and α7 exhibited a 23.5- and 2-fold lower mRNA expression
respectively compared to α3, α5, or β4 subunits (data not
shown). Whereas nAchR subunit β4 expression was significantly
down-regulated in patients with DD, as mRNA levels dropped
to 46% ± 7 of control values (Figure 2B), subunits β2,
α3, α5, and α7 showed no statistically significant alterations
(Figures 2A,C–E).
Confirmatory to gene expression analysis in the tunica
muscularis, site-specific gene expression in myenteric ganglia
retrieved by LMD revealed a significant down-regulation of
NRG1, ErbB3 and nAchR β4 in patients with DD by 26 ± 6%
(Figure 3A), 49 ± 13% (Figure 3B), and 32 ± 10% (Figure 3D)
of control values respectively, whereas the expression of ErbB2
remained unaltered (Figure 3C).
Immunohistochemistry of NRG1, ErbB2,
ErbB3, and nAchR β4 in Patients With DD
and Controls
NRG1, ErbB2, ErbB3, and nAchR β4 immunoreactive signals
were analyzed in patients with DD and compared to controls.
While controls displayed strong NRG1 immunoreactive signals
in both neurons and glial cells (Figure 4a), patients with
DD showed considerably decreased and patchy immunoreactive
signals in myenteric ganglia affecting both neuronal somata and
the ganglionic neuropil (Figure 4b). ErbB2 immunoreactivity
exhibited a punctuate staining pattern throughout the ganglia
with most intensive immunoreactive signals in neuronal somata.
No apparent differences between controls (Figure 4c) and
patients with DD (Figure 4d) could be observed. In contrast,
ErbB3 immunoreactive signals displayed a more homogeneous
staining pattern decorating both neuronal somata and the
ganglionic neuropil. Compared to controls (Figure 4e), patients
with DD (Figure 4f) showed decreased immunoreactive signals
for ErbB3, in particular in neuronal somata. nAchR β4
exhibited homogenous immunopositive signals in neuronal
somata and the ganglionic neuropil of controls (Figure 4g). In
patients with DD, nAchR β4 immunoreactivity was considerably
decreased (Figure 4h).
The lightmicroscopical findings (Figure 4) were confirmed
by subtle quantitative analysis of immunofluorescent signals
(Figure 5): patients with DD showed a significant decrease in
immunofluorescence intensity of NRG1 to 64± 7% (Figures 5a–
c), ErbB3 to 50± 10% (Figures 5g,h), and nAchRb4 to 57± 14%
(Figures 5j–l) compared to controls, while immunofluorescence
intensity of ErbB2 remained unaltered (Figures 5d–f).
Effects of NRG1 and GDNF on nAchR α3,
α5, α7, β2, β4 mRNA Expression in
Cultured Enteric Neurons
To estimate the impact of NRG1 on gene regulation of enteric
nAchR subunits, mRNA expression of nAchR subunits α3, α5,
α7, β2, and β4 was measured by RT-qPCR in rat enteric nerve
cell cultures exposed to NRG1. Effects evoked by NRG1 were
compared to those induced by the well characterized enteric
neurotrophic factor GDNF. While treatment with NRG1 had no
effect on gene expression of the nAchR subunit α3, α5, α7, and β2
(Figures 6A,C–E), NRG1 (2 ng/mL) induced a twofold increase
of mRNA expression levels of nAchRβ4 (Figure 6B). Higher
concentrations (20 ng/mL) showed not significant increase.
GDNF had no effect on gene expression of all nAchR subunits
measured (Figures 6A–E).
DISCUSSION
To our knowledge, this is the first study addressing deficits
of the NRG1-system and altered nAchR subunit composition
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FIGURE 1 | mRNA expression of the NRG1 system in the tunica muscularis of controls and patients with DD. mRNA expression of NRG1 and ErbB3 is significantly
down-regulated in patients with DD compared to controls (A,C), whereas the reduction of ErbB2 mRNA levels is not statistically significant (B). mRNA levels are
determined by qPCR; expression of target genes is normalized to mRNA expression of the house-keeping gene HPRT. Data are shown as mean ± SEM, n = 6–9
per experimental group, ∗p < 0.05 vs. control.
FIGURE 2 | mRNA expression of nAchR subunits in the tunica muscularis of controls and patients with DD. mRNA expression of nAchRb4 is significantly
down-regulated in patients with DD compared to controls (B), whereas mRNA expression levels of nAchR subunits b2, a3, a5, a7 levels showed no significant
difference compared to controls (A,C,D,E). mRNA levels are determined by qPCR; expression of target genes is normalized to mRNA expression of the
house-keeping gene HPRT. Data are shown as mean ± SEM, n = 6–9 per experimental group, ∗p < 0.05 vs. control.
in patients with DD and investigating in vitro possible links
between NRG1 and nAchR expression in the ENS. The
study reveals three important findings: (1) The expression
of NRG1 and its corresponding receptor ErbB3 is down-
regulated in enteric ganglia and intestinal musculature of patients
with DD compared to controls; (2) Whereas the expression
of nAchR subunit β4 is decreased in patients with DD,
other nAchR subunits remain unaltered; (3) NRG1 treatment
promotes the mRNA expression of nAchR subunit b4 in enteric
nerve cell cultures.
Neurotrophic Factors and Their
Corresponding Receptors in DD
The pathogenesis of DD is considered to be multifactorial.
Increasing evidence is given that DD is associated with an
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FIGURE 3 | Site-specific mRNA expression of the NRG1 system and
nAchRb4 in myenteric ganglia of controls and patients with DD. NRG1 (A) and
nAchRb4 (B) and ErbB3 (D) is site-specifically down-regulated in
LMD-isolated myenteric ganglia of patients with DD compared to controls.
ErbB2 (C) exhibited no significant difference. mRNA expression levels are
normalized to mRNA expression of the house-keeping gene HPRT. Data are
shown as mean ± SEM, n = 7–9 per experimental group. ∗p < 0.05 vs.
control, ∗∗∗p < 0.001 vs. control.
enteric neuropathy (Simpson et al., 2009) characterized by
remodeling of nerve tissue (Golder et al., 2003), impaired
intestinal motility patterns (Gallego et al., 2013), disturbed enteric
neurotransmission (Espin et al., 2014), and a relative loss of
enteric nerve cells (Iwase et al., 2005; Deduchovas et al., 2008;
Wedel et al., 2010). It has been shown that GDNF, a potent growth
factor for the ENS, is impaired not only in DD (Böttner et al.,
2013), but also in asymptomatic diverticulosis suggesting that a
deficient GDNF system may trigger the enteric nerve cell decrease
in DD (Barrenschee et al., 2017).
Neuregulin 1 is also a known growth factor for the ENS.
Whereas GDNF is mainly produced by the enteric musculature
(Böttner et al., 2013), NRG1 is primarily expressed by enteric
neuronal tissue (Barrenschee et al., 2015). Interestingly, GDNF
stimulates the expression of NRG1 in motor neurons both
in vitro and in vivo (Loeb and Fischbach, 1997; Loeb et al.,
2002), and it is known that locally applied GDNF induces
the release of NRG1 from neurons and their axons (Esper
and Loeb, 2009). Although in a previous study on enteric
nerve cell cultures, we could not confirm that GDNF enhances
the gene expression of NRG1 (Barrenschee et al., 2015), it is
suggestive that the decreased NRG1 protein expression observed
in DD is a consequence of a deficient GDNF system previously
described in DD.
Down-regulation of enteric neurotrophic factors and of
their corresponding receptors in patients with DD was first
FIGURE 4 | NRG1, ErbB2, ErbB3, and nAchR β4 immunoreactive signals in
myenteric ganglia of controls and patients with DD. Robust NRG1
immunoreactive signals (brown colored deposits) detected in myenteric
ganglia of controls (a) were considerably reduced in a patients with DD (b).
The punctuate staining pattern of ErbB2 was equally discernible in both
controls (c) and patients with DD (d), while ErbB3 immunoreactive signals
were decreased in patients with DD (f) compared to controls (e), in particular
regarding neuronal somata (arrowheads). nAchR β4 immunoreactive signals
detected in myenteric ganglia of controls (g) are reduced in both neuronal
somata and the neuropil of myenteric ganglia from patients with DD (h). Scale
bars: 20 µm.
investigated by Böttner et al. (2013), who observed decreased
gene expression levels of the receptors for GDNF, RET, and
GFRα1. A refined analysis revealed that the down-regulation
of both receptors was most pronounced in myenteric ganglia
(Barrenschee et al., 2017), thereby resembling the actual
data on the NRG1-ErbB2/ErbB3 system in DD: The ErbB3
receptor predominantly expressed in enteric neuronal tissue
is diminished in DD, whereas the ErbB2 receptor primarily
expressed by enteric smooth muscle cells (Barrenschee et al.,
2015) is not affected.
It is important to note that only a complex of both
receptors can lead to phosphorylation and subsequent signaling
in neuronal cells, since ErbB3 lacks kinase domain and ErbB2
lacks a ligand binding site (Holbro et al., 2003). Although
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FIGURE 5 | Quantitative analysis of NRG1 (a–c), ErbB2 (d–f), ErbB3 (g–i), and nAchR (j–l) β4 immunofluorescent signals in myenteric ganglia of controls and
patients with DD. Immunofluorescent signals (green) in myenteric ganglia (marked by white line) of NRG1, ErbB3, and nAchR β4 are significantly reduced in patients
with DD compared to controls. Data are shown as corrected mean gray value normalized to controls presented as mean ± SEM, n = 8 per experimental group,
∗∗p < 0.01 vs. control, ∗∗∗p < 0.001 vs. control. Nuclear stain with DAPI, bars = 50 µm.
not proven in detail by means of phosphorylation studies, the
reduction of ErbB3 both at mRNA and protein level suggests
a disturbed NRG1-ErbB2/ErbB3 signaling in enteric neuronal
tissue. Thus, our findings indicate that the enteric neuropathy
associated with DD is characterized by an altered receptor status
of several enteric neurotrophic growth factors which in turn may
lead to a disturbed signaling in enteric neuronal tissue.
In addition, the data suggest that the loss of GDNF not
only leads to the down-regulation of its own receptors (Böttner
et al., 2013), but may also cause down-regulation of NRG1
and ErbB3 in enteric neuronal tissue. A functional interaction
between NRG1 and GDNF signaling was observed previously by
Gui et al. (2013), who found a down-regulation of ErbB3 mRNA
expression in response to GDNF stimulation. We could confirm
a down-regulation of ErbB3 in enteric nerve cell cultures induced
by GDNF and NRG1 (Barrenschee et al., 2015).
It is likely that deficiency of the GDNF system in patients with
asymptomatic and symptomatic DD results in a loss of myenteric
neurons which in turn leads to a loss of NRG1 expression.
The decrease in NRG1 being a potent neurotrophic factor of
the ENS and the concomitant down-regulation of its ErbB3
receptor further impairs the maintenance of enteric neuronal
tissue and, thus, contributes to the enteric neuropathy in DD.
Further studies are required to unravel whether a deficiency of
the NRG1/ErbB2/ErbB3 system observed in DD may also occur
in asymptomatic diverticulosis.
Enteric Expression and Regulation of
nAchR Subunits in DD
Since nAchRs are critical for gastrointestinal motility (Galligan
and North, 2004) and DD is characterized by disturbed intestinal
motility (Parks and Connell, 1969; Wedel et al., 2015), we
investigated the mRNA expression of those nAchR subunits
known to be present in the ENS: the ligand binding nAchR
subunits α3, α5, α7 and the structural nAchR subunits β2, β4.
While the structural nAchR subunit β4 was down-regulated both
at gene and protein level in patients with DD compared to
controls, the other subunits remained unaffected.
In autonomic ganglia, the α3β4 subunit combination is
considered to be the most prevalent combination (Park et al.,
2006). This pattern seems to be conserved as Garza et al. (2009)
observed in the ENS of neonatal rats by in situ hybridization
that the majority of heteromeric nAchRs are also composed of
α3β4 (with or without α5), while only a few consist of α3 and
β2 subunits. In line with Garza et al. (2009), we also found a
lower β2 subunit mRNA expression when compared to that of
β4. Noteworthy their semi-quantitative study on the expression
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FIGURE 6 | mRNA expression of nAchR receptor subunits in enteric nerve cell cultures after exposure to NRG1 or GDNF. Treatment of cultured enteric nerve cells
with NRG1 (2 ng/mL) induced an increased mRNA expression of nAchR subunit β4 (B), while gene expression levels of all other nAchR subunits (A,C–E) were not
significantly altered. Treatment of GDNF did not show any significant effects on gene expression profiles of nAchR subunits. Expression levels of the target gene were
normalized to expression of the house-keeping gene HPRT. Data are shown as mean ± SEM, n = 15–18 per experimental group, ∗∗p < 0.01 vs. control.
of nAchR subunits α3, α5, α7, β2, β4 in the large intestine of the
rat matched with our observations.
We found a diminished myenteric β4 subunit expression in
patients with DD when compared to control. Since it is known
that deficiency of the nAchR subunit β4 results in reduced
ileal contractile response to nicotinic agonists in mice (Wang
et al., 2003), a dysfunctional nAchR receptor may contribute
to the impairment of gastrointestinal motility observed in
DD. A compensation of structural subunit β4 to β2 with
altered activation kinetics or reduced sensitivity to agonists and
antagonist previously described in nerve cell cultures (Nelson
et al., 2001; Wang et al., 2003) is rather unlikely, since there is
no significant change in the expression of the structural subunit
β2 in DD.
In our cell culture experiments, we observed a significant
upregulation of nAchR β4 upon NRG1 stimulation, whereas
other subunits remained unaffected. This finding is similar
to that from Kim et al. (2013), who reported that NRG1
up-regulated the expression of the nAchR α3 and β4 subunits
in both sympathetic and parasympathetic major pelvic ganglion
neurons from adult rats. In addition, NRG1 was shown to be
involved in the formation of nicotinic synapses by increasing the
expression of nAchR subunits α3, α5, α7, and β4 in embryonic
chick sympathetic neurons (Yang et al., 1998). However, we
did not found any other receptor subunits regulated by NRG1,
suggesting, that in the human ENS only the β4 subunit is
regulated by this growth factor.
CONCLUSION
Taken together, our results give first evidence that DD is
associated with a decrease of the neurotrophic factor NRG1
and its corresponding receptor ErbB3. The in vitro data
illustrate that NRG1 promotes the expression of the nAchR
β4 subunit, that is also down-regulated in DD suggesting a
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link between NRG1 and nAchRβ4 expression. Thus, lack of
NRG1 in DD may lead to a decrease of nAchRβ4 and
subsequently a reduced receptor configuration which in turn may
contribute to the impaired intestinal motility observed in DD.
Obviously, the enteric neuropathy previously described in DD
also involves deficiency of several enteric neurotrophic factors
and of neurotransmitter receptors.
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